Pharma market

Revenue growth to moderate to 8-10 per cent in FY2025, post a healthy 13-14 per cent YoY expansion in FY2024

An anticipated 11 assets in the late-stage pipeline will enter the CD market during the forecast period

Corporation's shareholding in Sun Pharma has decreased from 5.023 per cent to 3.012 per cent of the paid-up capital of the said…

Pharma revenue up 50 per cent with expanding contribution from Latin America

The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…

Growth in FY2023 is expected to be supported by growth of seven-to-nine per cent in the domestic market, 12-14 per cent in the…

The industry reported 163 Venture Capital (VC) deals worth $3.1 billion in March 2022, compared to the last 12-month average…

The findings suggest a robust and prosperous year ahead for the contract services industry

One big-ticket deal contributed 68.4 per cent of total deal value in June 2021

The study is being done with a view to developing a better understanding of the competition landscape in the sector